It curbs hunger by altering the brain's satiety signals and delays stomach emptying, promoting satisfaction from smaller meals
While compounding may still be permitted in limited situations, such as when patient-specific needs cannot be met by FDA-approved products, access has narrowed, leaving medications like Mounjaro and Zepbound as the primary options for most patients
The FDA has recently added oral semaglutide options, further broadening treatment possibilities
The survey was tested and deemed reliable in both English and Spanish versions
As a Circle member, you can engage with your community to share insights and support one another in this important process
In May 2025, Septerna, Inc